Has Henry Chen received payments from drug or device companies?

Yes. Drug and device makers reported $1,987 in general payments to Henry Chen across 85 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Henry Chen did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Henry Chen come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Henry Chen

Internal Medicine · Bradenton, FLNPI 1326483009

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 85 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 21.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,047 and has fallen 98.0% since, to $21 in 2025.

$1,987in general payments, 2019–2025

Across 85 payments — averaging $23.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AstraZeneca$435
Acadia Pharmaceuticals Inc$246
Pfizer$201
AbbVie$188
GSK$166
Novo Nordisk$159
plus $591 from 15 others

What the payments were for

Food & beverage$1,987100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AstraZeneca	17	$435
Acadia Pharmaceuticals Inc	2	$246
Pfizer	14	$201
AbbVie	7	$188
GSK	5	$166
Novo Nordisk	9	$159
Amgen	5	$98
THD America, Inc.	1	$91
Amarin Pharma, Inc.	3	$60
Boehringer Ingelheim	4	$58
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	3	$49
Lilly USA, LLC	4	$48
Sonex Health, Inc.	1	$38
Radius Health, Inc.	2	$33
Astellas Pharma US Inc	2	$24
Scilex Pharmaceuticals Inc.	1	$20
Johnson & Johnson	1	$19
Sunovion Pharmaceuticals Inc.	1	$15
Boston Scientific	1	$14
Therapeuticsmd, Inc.	1	$13
Merck	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,987 in reported general payments places this provider in the 80th percentile of 8,530 internal medicine providers in Florida.

See all internal medicine providers in Florida →

Other internal medicine in Bradenton

Ian KahaneBradenton$126K
Joseph PaceBradenton$69K
Haytham ElgammalMiami$2.2M
Keith RubinFort Lauderdale$2M
Michael SensionFort Lauderdale$1M
Quang NguyenOcala$434K
Luis Correa LunaSanford$412K
Michael OleksykFort Myers$365K
Andrew KuykendallTampa$322K
Howard FederoffCoconut Grove$302K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →